tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of John Hsu, 12 are a BUY (100%).
Analyst John Hsu, currently employed at RAYMOND JAMES, carries an average stock price target met ratio of 100% that have a potential upside of 19.65% achieved within 221 days. Previously, John Hsu worked at CREDIT SUISSE.
John Hsu’s has documented 22 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on QDEL, Quidel at 19-Mar-2020.
Analyst best performing recommendations are on NEO (NEOGENOMICS).
The best stock recommendation documented was for NEO (NEOGENOMICS) at 10/23/2018. The price target of $16 was fulfilled within 7 days with a profit of $2.01 (14.37%) receiving and performance score of 20.52.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 20-Jul-2021
$74
$10.32 (16.21%)
$60
Hold Since 26-Feb-2021
$46
$-17.68 (-27.76%)
$25
1 months 30 days ago
(31-Jul-2026)
11/11 (100%)
$2.29 (5.24%)
232
Hold Since 02-May-2025
$21
$-42.68 (-67.02%)
$18
7 months 5 days ago
(25-Feb-2026)
5/5 (100%)
$2.54 (13.76%)
32
Buy Since 08-Oct-2024
$22
$-41.68 (-65.45%)
$22
1 years 7 days ago
(23-Sep-2025)
10/13 (76.92%)
$6.43 (41.30%)
358
Buy Since 17-Apr-2024
$40
$-23.68 (-37.19%)
$40
1 years 4 months 25 days ago
(05-May-2025)
6/6 (100%)
$24.83 (163.68%)
439
What Year was the first public recommendation made by John Hsu?
